New Jersey has eased some provisions in a rule that sought to restrict gifts and payments that drugmakers can give to physicians, according to STAT.
Pharmacy
The FDA has finalized its long-awaited guidance on when biosimilars can be considered interchangeable with biologics.
Specialty drugmaker Insys said Monday that it may be forced to file for Chapter 11 bankruptcy because it can't afford the legal costs related to a U.S. Justice Department probe, and its shares plummeted on the news, according to CNBC.
Novartis and Teva Pharmaceuticals, two of the defendants named in a wide-reaching lawsuit against generic drugmakers, have vowed to fight the allegations of price-fixing brought against them, according to a BioSpace news report.
In an unusual move, Novartis began offering price discounts in negotiations with insurers for its pricey gene therapy for spinal muscular atrophy — but there's a catch, according to Reuters.
Advertisement
Attorneys general from 44 states are suing the nation's largest generic drugmakers, claiming they conspired to inflate prices of more than 100 generic drugs by as much as 1,000 percent, according to The New York Times.
The owner of two pharmacies in Michigan was charged with bilking health insurance plans out of millions of dollars this week, according to The Detroit News.
Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.
Gilead Sciences has agreed to donate drugs to the federal government that reduce the risk of HIV transmission for up to 200,000 people a year, HHS Secretary Alex Azar announced May 9.
A judge denied an emergency bid from Johnson & Johnson to transfer 2,400 state lawsuits tied to its baby powder immediately to a federal court in Delaware, according to Bloomberg.